HOLX

Hologic
D

HOLX

54.260
USD
-0.22
(-0.40%)
مغلق
حجم التداول
66,767
الربح لكل سهم
4
العائد الربحي
-
P/E
23
حجم السوق
12,091,583,048
أصول ذات صلة
ABT
ABT
-0.240
(-0.18%)
131.240 USD
BDX
BDX
-0.820
(-0.48%)
171.380 USD
DGX
DGX
1.620
(0.96%)
171.200 USD
ISRG
ISRG
-3.15
(-0.58%)
539.50 USD
R
RGEN
-2.440
(-2.03%)
118.050 USD
SYK
SYK
-1.79
(-0.47%)
376.66 USD
T
TDOC
-0.09000
(-1.31%)
6.80000 USD
TMO
TMO
-6.77
(-1.69%)
393.52 USD
المزيد
الأخبار المقالات

العنوان: Hologic

القطاع: Healthcare
الصناعة: Medical Instruments & Supplies
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.